Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
3SBio ( (HK:1530) ) has issued an announcement.
3SBio Inc. announced the results of its Annual General Meeting (AGM) held on June 25, 2025, where all proposed resolutions were passed by poll. The company also declared a final dividend payment and announced changes to its Nomination Committee. These developments are likely to impact the company’s governance structure and shareholder returns, potentially strengthening its position in the biotechnology sector.
The most recent analyst rating on (HK:1530) stock is a Buy with a HK$9.46 price target. To see the full list of analyst forecasts on 3SBio stock, see the HK:1530 Stock Forecast page.
More about 3SBio
3SBio Inc. is a biotechnology company incorporated in the Cayman Islands, focusing on the development, manufacturing, and marketing of biopharmaceutical products. The company is primarily involved in the healthcare industry, with a market focus on innovative therapies for various medical conditions.
Average Trading Volume: 59,718,969
Technical Sentiment Signal: Buy
Current Market Cap: HK$54.33B
For an in-depth examination of 1530 stock, go to TipRanks’ Overview page.